A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis
Wolfgang C. Winkelmayer, Anthonie W.A. Lensing, Ravi Thadhani, Kenneth W. Mahaffey, Michael Walsh, Ákos F. Pap, Stefan Willmann, Kirstin Thelen, Sophie Hodge, Alexander Solms, Sheila Jean McNeill Ingham, John W. Eikelboom
Topics & Concepts
HemodialysisMedicineAntithromboticRandomized controlled trialInternal medicineKidney diseaseIntensive care medicineSurgeryAtrial Fibrillation Management and OutcomesIntracerebral and Subarachnoid Hemorrhage ResearchVitamin K Research Studies